SENSORY ANALYSIS OF LIQUID ORAL DOSAGE FORMS ANTACID SUSPENSIONS

被引:0
|
作者
REYES, MD
PERALTA, RD
VALDES, IC
FAHARA, MC
SAUCEDO, CT
机构
[1] CTR INVEST QUIM APLICADA, SALTILLO 25100, COAHUILA, MEXICO
[2] UNIV AUTONOMA COAHUILA, FAC CIENCIAS QUIM, SALTILLO 25280, COAHUILA, MEXICO
[3] SA CV, QUIM & FARM, RAMOS ARIZPE 25900, COAHUILA, MEXICO
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sensory analysis of pharmaceutical oral dosage forms can be used effectively in product development and quality control to improve patient acceptance of the drug. In this work, sensory analysis is applied to detect consumer preference for formulations. of aluminum and magnesium hydroxide antacid suspensions. A ranking test was applied to six peppermint flavored commercial samples (identified from A to F) of the antacid with the same therapeutical potency. The samples corresponded to four different formulations and six batches from three manufacturers. The ranking test was applied in duplicate to ten judges (ages 20-34) trained in the method and in the main sensory characteristics of the product. The coded samples were presented randomly in duplicate to each judge with six replications, and results were recorded in a preference scale from 1 to 6 (1 = most preferred). Statistical analysis of the data considered the sample as the only cause for variation and the minimum significant difference was determined at confidence levels of alpha = 0.01 and alpha = 0.05. The results show a highly significant preference (alpha = 0.01) in sample F over A, B, D and E. At alpha = 0.05, sample F was preferred over all the others, whereas formulations A and D were the least preferred at both significance levels. These results demonstrate that sensory analysis can be applied succesfully in product selection for the patient, formulation development and as a quality control tool in antacid suspensions.
引用
收藏
页码:2845 / 2857
页数:13
相关论文
共 50 条
  • [1] DEVELOPMENT OF ORAL LIQUID DOSAGE FORMS OF ACETAZOLAMIDE
    PARASRAMPURIA, J
    DASGUPTA, V
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (09) : 835 - 836
  • [2] THE DEVELOPMENT OF ORAL LIQUID DOSAGE FORMS OF METRONIDAZOLE
    MATHEW, M
    DASGUPTA, V
    BETHEA, C
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1993, 18 (04) : 291 - 294
  • [4] INVITRO INTERACTIONS OF ORAL HEMATINICS AND ANTACID SUSPENSIONS
    COSTE, JF
    DEBARI, VA
    KEIL, LB
    NEEDLE, MA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 22 (01): : 205 - 216
  • [5] Stability of dapsone in two oral liquid dosage forms
    Nahata, MC
    Morosco, RS
    Trowbridge, JM
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (7-8) : 848 - 850
  • [6] BIOAVAILABILITY OF VALSARTAN LIQUID ORAL DOSAGE FORMS.
    Sunkara, G.
    Bende, G.
    Mendonza, A.
    Solar-Yohay, S.
    Biswal, S.
    Neelakantham, S.
    Wagner, R.
    Calder, M.
    Smith, H.
    Zhang, Y.
    Jarugula, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S122 - S123
  • [7] Hyperspectral techniques in analysis of oral dosage forms
    Hamilton, SJ
    Lowell, AE
    Lodder, RA
    JOURNAL OF BIOMEDICAL OPTICS, 2002, 7 (04) : 561 - 570
  • [8] THE INVITRO NEUTRALIZING EFFICACY OF DIFFERENT DOSAGE FORMS OF ANTACID PREPARATIONS
    PAWLACZYK, J
    KOKOT, Z
    GLOWKA, F
    ACTA POLONIAE PHARMACEUTICA, 1984, 41 (06): : 671 - 677
  • [9] A comparative in vitro analysis of some antacid suspensions
    Spasova L.G.
    Kafedzhiiski S.K.
    Pharmaceutical Chemistry Journal, 1999, 33 (2) : 104 - 105
  • [10] EFFECT OF FLAVORING OILS ON PRESERVATIVE CONCENTRATIONS IN ORAL LIQUID DOSAGE FORMS
    CHEMBURKAR, PB
    JOSLIN, RS
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (03) : 414 - 417